- Home
- CDXC vs LEU Comparison
CDXC vs LEU Comparison
Compare CDXC & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXC
- LEU
- Stock Information
- Founded
- CDXC 1999
- LEU 1998
- Country
- CDXC United States
- LEU United States
- Employees
- CDXC N/A
- LEU N/A
- Industry
- CDXC Medicinal Chemicals and Botanical Products
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- CDXC Health Care
- LEU Industrials
- Exchange
- CDXC Nasdaq
- LEU Nasdaq
- Market Cap
- CDXC 546.9M
- LEU 599.9M
- IPO Year
- CDXC N/A
- LEU 1998
- Fundamental
- Price
- CDXC $7.63
- LEU $80.01
- Analyst Decision
- CDXC Strong Buy
- LEU Buy
- Analyst Count
- CDXC 2
- LEU 2
- Target Price
- CDXC $8.00
- LEU $92.00
- AVG Volume (30 Days)
- CDXC 3.0M
- LEU 1.9M
- Earning Date
- CDXC 10-31-2024
- LEU 10-28-2024
- Dividend Yield
- CDXC N/A
- LEU N/A
- EPS Growth
- CDXC N/A
- LEU 50.42
- EPS
- CDXC 0.02
- LEU 4.70
- Revenue
- CDXC $91,668,000.00
- LEU $394,000,000.00
- Revenue This Year
- CDXC $18.64
- LEU $25.25
- Revenue Next Year
- CDXC $20.72
- LEU $2.84
- P/E Ratio
- CDXC $388.80
- LEU $17.04
- Revenue Growth
- CDXC 9.95
- LEU 14.94
- 52 Week Low
- CDXC $1.32
- LEU $33.51
- 52 Week High
- CDXC $7.85
- LEU $118.36
- Technical
- Relative Strength Index (RSI)
- CDXC 75.32
- LEU 50.01
- Support Level
- CDXC $6.80
- LEU $64.56
- Resistance Level
- CDXC $7.67
- LEU $95.00
- Average True Range (ATR)
- CDXC 0.58
- LEU 9.35
- MACD
- CDXC 0.07
- LEU -2.76
- Stochastic Oscillator
- CDXC 91.16
- LEU 50.74
About CDXC ChromaDex Corporation
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.